Nonarterialized orthotopic liver transplantation with no immunosuppression was performed in 13 mouse-strain combinations. Two strain combinations with major histocompatibility complex class I and class II and minor histocompatibility complex disparity had 20% and 33% survival of more than 100 days, but the other 11 combinations, including four that were fully allogeneic and all with only class ...

Minor histocompatibility antigens are highly immunogeneic polymorphic peptides playing crucial roles in the clinical outcome of HLA-identical allogeneic stem cell transplantation. Although the introduction of genome-wide association-based strategies significantly has accelerated the identification of minor histocompatibility antigens over the past years, more efficient, rapid and robust identif...

Aim . To reveal the significance of major histocompatibility complex and human leukocyte antigen evolutionary divergence in transplantation allogeneic hematopoietic stem cells. The article traces evolution discusses reasons for its formation on example recognition system invertebrates, plants, jawed vertebrates humans. concepts immunopeptidome have been defined; data their impact therapy outcom...

Mov mouse strains differ from their respective, coisogenic partner strains by the embryonic, germ-line introduction of Moloney murine leukemia virus genomes. The possibility that retroviral insertions into the mouse genome resulted in gain or loss mutations at non-H-2 histocompatibility loci was investigated by reciprocal skin grafting between Mov mice and mice from coisogenic, background strai...

h”mno1ogic and genetic bases of histocompatibility are well established. TFFe rejection of an incompatible graft is due to an immunologic reaction of the host against the graft of the donor which contains one or more antigens lacking in the tissues of the host. The antigens involved in transplantation immunity are known to be genetically determined. These determinants, defined as histocompatibi...

The p53 tumour suppressor has an important role in cancer cells. Here we show that p53 regulates expression of major histocompatibility complex I on the cell surface. We show that the tumour cell line HCT116, which lacks p53 exhibits significantly lower major histocompatibility complex I expression than its wild-type counterpart. Using a combination of chromatin immunoprecipitation sequencing a...